Operating results for the quarter ended December 31, 2019 after the market closes on Thursday, January 30, 2020, and will host a conference call at 5:00 p.m. ET that day to discuss those results.
IRVINE, Calif., Jan. 16, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended December 31, 2019 after the market closes on Thursday, January 30, 2020, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. For 72 hours following the call, an audio replay can be accessed by dialing (877) 660-6853 or (201) 612-7415 and using conference number 13697863. The call will also be available via live or archived webcast on the “Investor Relations” section of the Edwards web site at ir.edwards.com. About Edwards Lifesciences Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences and the stylized E logo are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.
SOURCE Edwards Lifesciences Corporation | ||
Company Codes: NYSE:EW |